These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 15536019

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Homocysteine enhances LDL fatty acid peroxidation, promoting microalbuminuria in type 2 diabetes.
    Kassab A, Ajmi T, Issaoui M, Chaeib L, Miled A, Hammami M.
    Ann Clin Biochem; 2008 Sep; 45(Pt 5):476-80. PubMed ID: 18753419
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diacylglycerol oil ingestion in type 2 diabetic patients with hypertriglyceridemia.
    Yamamoto K, Takeshita M, Tokimitsu I, Watanabe H, Mizuno T, Asakawa H, Tokunaga K, Tatsumi T, Okazaki M, Yagi N.
    Nutrition; 2006 Jan; 22(1):23-9. PubMed ID: 16289977
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alpha-tocopherol supplementation decreases electronegative low-density lipoprotein concentration [LDL(-)] in haemodialysis patients.
    Mafra D, Santos FR, Lobo JC, de Mattos Grosso D, Barreira AL, Velarde LG, Abdalla DS, Leite M.
    Nephrol Dial Transplant; 2009 May; 24(5):1587-92. PubMed ID: 19176686
    [Abstract] [Full Text] [Related]

  • 10. Plasma fatty acids and lipoproteins in type 2 diabetic patients.
    Lapolla A, Sartore G, Della Rovere GR, Romanato G, Zambon S, Marin R, Manzato E, Fedele D.
    Diabetes Metab Res Rev; 2006 May; 22(3):226-31. PubMed ID: 16308886
    [Abstract] [Full Text] [Related]

  • 11. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
    de Luis DA, Fernandez N, Arranz ML, Aller R, Izaola O, Romero E.
    J Diabetes Complications; 2005 May; 19(1):42-6. PubMed ID: 15642489
    [Abstract] [Full Text] [Related]

  • 12. Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes.
    Sampson MJ, Braschi S, Willis G, Astley SB.
    Clin Sci (Lond); 2005 Aug; 109(2):189-97. PubMed ID: 15853770
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Abnormal particle size of lipoprotein in non-insulin-dependent diabetics and nondiabetics with and without hyperlipidemia.
    Nakajo Y, Tanaka A, Uchimura I.
    Bull Tokyo Med Dent Univ; 1991 Dec; 38(4):63-71. PubMed ID: 1764762
    [Abstract] [Full Text] [Related]

  • 15. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study.
    Goff DC, D'Agostino RB, Haffner SM, Otvos JD.
    Metabolism; 2005 Feb; 54(2):264-70. PubMed ID: 15690322
    [Abstract] [Full Text] [Related]

  • 16. High insulin levels and increased low-density lipoprotein oxidizability in pediatric patients with systemic lupus erythematosus.
    Posadas-Romero C, Torres-Tamayo M, Zamora-González J, Aguilar-Herrera BE, Posadas-Sánchez R, Cardoso-Saldaña G, Ladrón de Guevara G, Solis-Vallejo E, El Hafidi M.
    Arthritis Rheum; 2004 Jan; 50(1):160-5. PubMed ID: 14730612
    [Abstract] [Full Text] [Related]

  • 17. Heterogeneity of low-density lipoprotein particle number in patients with type 2 diabetes mellitus and low-density lipoprotein cholesterol <100 mg/dl.
    Cromwell WC, Otvos JD.
    Am J Cardiol; 2006 Dec 15; 98(12):1599-602. PubMed ID: 17145217
    [Abstract] [Full Text] [Related]

  • 18. Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis.
    Dornbrook-Lavender KA, Joy MS, Denu-Ciocca CJ, Chin H, Hogan SL, Pieper JA.
    Pharmacotherapy; 2005 Mar 15; 25(3):335-44. PubMed ID: 15843280
    [Abstract] [Full Text] [Related]

  • 19. Decrease in the particle size of low-density lipoprotein (LDL) by oxidation.
    Hidaka A, Inoue K, Kutsukake S, Adachi M, Kakuta Y, Kojo S.
    Bioorg Med Chem Lett; 2005 Jun 02; 15(11):2781-5. PubMed ID: 15911255
    [Abstract] [Full Text] [Related]

  • 20. Microalbumiuria and associated risk factors in type II diabetics.
    Hashim R, Khalil-ur-Rehman, Ahmed TA, Mushtaq S, Zafar L, Attique M.
    J Coll Physicians Surg Pak; 2004 Feb 02; 14(2):84-7. PubMed ID: 15228869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.